RevolKa raised funds through a startup loan program
RevolKa announces the closing of ￥250 million series A extension funding to accelerate Drug-Discovery programs
RevolKa announces the closing of ￥250 million series A extension funding to accelerate Drug-Discovery programs
RevolKa Started joint research of a drug discovery program for rare diseases
RevolKa Started joint research of a drug discovery program for rare diseases
RevolKa launched a drug discovery program for rare diseases
RevolKa launched a drug discovery program for rare diseases
RevolKa completed the contract research with SEKISUI CHEMICAL CO., LTD
RevolKa completed the contract research with SEKISUI CHEMICAL CO., LTD
LATEST ARTICLE
ARCHIVE
- 2024/11 (1)
- 2024/10 (1)
- 2024/08 (4)
- 2024/07 (4)
- 2024/05 (2)
- 2024/04 (2)
- 2024/03 (1)
- 2024/02 (4)
- 2024/01 (2)
- 2023/12 (2)
- 2023/11 (1)
- 2023/10 (2)
CATEGORY
View allTAG